Publications of Julita Piasecka

Rüdiger, D., Piasecka, J., Küchler, J., Pontes, C., Laske, T., Kupke, S. Y., & Reichl, U. (2024)Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”iScience, 27 (4), 109421doi: 10.1016/j.isci.2024.109421.

Pelz, L., Dogra, T., Piasecka, J., Rüdiger, D., Bälkner, M., Boehme, J. D., Kershaw, O., Volckmar, J., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo EfficacyPresented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Pelz, L., Dogra, T., Piasecka, J., Rüdiger, D., Bälkner, M., Boehme, J. D., Volckmar, J., Bruder, D., Kupke, S. Y., & Reichl, U.Engineered influenza vectors for use as broadly-acting antivirals and live nasal vaccines: design, manufacture and in vivo efficacyPresented at: 9^th European Congress of Virology (ECV)Cavtat/Dubrovnik (Croatia), April 27, 2025.

Piasecka, J., Kupke, S. Y., & Reichl, U.Genetically engineered influenza defective interfering particles with enhanced immune activation potential and antiviral efficacy in vitroPresented at: 9^th European Congress of Virology (ECV)Cavtat/Dubrovnik (Croatia), April 27, 2025.

Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”Presented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Rüdiger, D., Piasecka, J., Küchler, J., Kupke, S. Y., & Reichl, U.The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanismsPresented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Rüdiger, D., Piasecka, J., Küchler, J., Kupke, S. Y., & Reichl, U.The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanismsPresented at: 9^th European Congress of Virology (ECV)Cavtat/Dubrovnik (Croatia), April 27, 2025.

Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Mechanisms of antiviral action of the influenza defective interfering particle “OP7”Presented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Mechanisms of antiviral action of the influenza defective interfering particle “OP7”Presented at: 28th ESACT MeetingEdinburgh (Scotland), June 23, 2024.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviralPresented at: 8^th European Congress of VirologyGdańsk (Poland), May 4, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7Presented at: 32^nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviralPresented at: 17^th Vaccine CongressGlasgow (Scotland), September 24, 2023.